IPO Lockup Expirations

A lock-up on an IPO prevents major shareholders and company insiders from selling shares in the company for a specified number of days following an IPO to prevent the market from being flooded with too much supply of a company's stock. Following the expiration of the lock-up period, restrictions preventing a company's employees and other major shareholders from selling their stock are lifted. Lock-up expirations often coincide with a 1-3% drop in the company's stock because of the increased number of available shares in the company. More about lock-up periods.

CompanyCurrent PriceExpiration DateNumber of SharesInitial Share PriceOffer SizeDate Priced
AUVI
Applied UV
$9.913/1/20211,000,000$5.00$5,000,0008/31/2020
CMLFU
CM Life Sciences
$18.653/1/202138,500,000$10.00$385,000,0009/2/2020
PRFX
PainReform
$4.703/1/20212,500,000$8.00$20,000,0009/1/2020
BCTG
BCTG Acquisition
$11.103/2/202114,500,000$10.00$145,000,0009/3/2020
INAQU
INSU Acquisition Corp. II
$20.003/2/202120,000,000$10.00$200,000,0009/3/2020
CAPAU
HighCape Capital Acquisition
$13.913/3/202110,000,000$10.00$100,000,0009/4/2020
Snowflake logo
SNOW
Snowflake
$220.753/5/202128,000,000$120.00$3,360,000,0009/16/2020
ITACU
Industrial Tech Acquisitions
$11.313/8/20217,500,000$10.00$75,000,0009/9/2020
SVACU
Starboard Value Acquisition
$10.333/9/202136,000,000$10.00$360,000,0009/10/2020
TWCTU
TWC Tech Holdings II
$10.503/10/202152,500,000$10.00$525,000,0009/11/2020
JFrog logo
FROG
JFrog
$50.793/15/202111,568,218$44.00$509,001,5929/16/2020
Metacrine logo
MTCR
Metacrine
$7.833/15/20216,540,000$13.00$85,020,0009/16/2020
Outset Medical logo
OM
Outset Medical
$51.193/15/20218,951,111$27.00$241,679,9979/15/2020
Snowflake logo
SNOW
Snowflake
$220.753/15/202128,000,000$120.00$3,360,000,0009/16/2020
SAIIU
Software Acquisition Group Inc. II
$11.423/15/202115,000,000$10.00$150,000,0009/15/2020
StepStone Group logo
STEP
StepStone Group
$34.433/15/202117,500,000$18.00$315,000,0009/16/2020
STWOU
ACON S2 Acquisition
$10.203/16/202125,000,000$10.00$250,000,0009/17/2020
American Well logo
AMWL
American Well
$19.353/16/202141,222,222$18.00$741,999,9969/17/2020
Broadstone Net Lease logo
BNL
Broadstone Net Lease
$0.003/16/202133,500,000$17.00$569,500,0009/17/2020
Dyne Therapeutics logo
DYN
Dyne Therapeutics
$15.813/16/202112,251,578$19.00$232,779,9829/17/2020
PTVE
Pactiv Evergreen
$15.783/16/202141,026,000$14.00$574,364,0009/17/2020
Sumo Logic logo
SUMO
Sumo Logic
$19.593/16/202114,800,000$22.00$325,600,0009/17/2020
AHACU
Alpha Healthcare Acquisition
$13.853/17/202110,000,000$10.00$100,000,0009/18/2020
Athira Pharma logo
ATHA
Athira Pharma
$19.013/17/202112,000,000$17.00$204,000,0009/18/2020
COMPASS Pathways logo
CMPS
COMPASS Pathways
$38.443/17/20217,500,000$17.00$127,500,0009/18/2020
NMMCU
North Mountain Merger
$10.653/17/202111,500,000$10.00$115,000,0009/18/2020
Vitru logo
VTRU
Vitru
$14.903/17/20216,000,000$16.00$96,000,0009/18/2020
Unity Software logo
U
Unity Software
$100.343/17/202125,000,000$52.00$1,300,000,0009/18/2020
ACTCU
ArcLight Clean Transition
$20.623/22/202125,000,000$10.00$250,000,0009/23/2020
Bentley Systems logo
BSY
Bentley Systems
$43.913/22/202110,750,000$22.00$236,500,0009/23/2020
Corsair Gaming logo
CRSR
Corsair Gaming
$32.293/22/202114,000,000$17.00$238,000,0009/23/2020
FCACU
Falcon Capital Acquisition
$10.673/22/202130,000,000$10.00$300,000,0009/22/2020
GoodRx logo
GDRX
GoodRx
$37.623/22/202134,615,384$33.00$1,142,307,6729/23/2020
VIHAU
VPC Impact Acquisition
$15.463/22/202120,000,000$10.00$200,000,0009/23/2020
LSF
Laird Superfood
$0.003/22/20212,650,000$22.00$58,300,0009/23/2020
Taysha Gene Therapies logo
TSHA
Taysha Gene Therapies
$24.013/23/20217,869,566$20.00$157,391,3209/24/2020
Amesite logo
AMST
Amesite
$4.883/24/20213,000,000$5.00$15,000,0009/25/2020
FTIVU
Fintech Acquisition Corp. IV
$11.363/24/202120,000,000$10.00$200,000,0009/25/2020
Graybug Vision logo
GRAY
Graybug Vision
$7.453/24/20215,625,000$16.00$90,000,0009/25/2020
GLSI
Greenwich LifeSciences
$30.743/24/20211,260,870$6.00$7,250,0039/25/2020
PMV Pharmaceuticals logo
PMVP
PMV Pharmaceuticals
$42.443/24/202111,765,000$18.00$211,770,0009/25/2020
PRLD
Prelude Therapeutics
$58.393/24/20218,325,000$19.00$158,175,0009/25/2020
SYTA
Siyata Mobile
$8.943/24/20212,100,000$6.00$12,600,0009/25/2020
VACQU
Vector Acquisition
$13.403/24/202130,000,000$10.00$300,000,0009/25/2020
VIAO
VIA optronics
$13.473/24/20216,250,000$15.00$93,750,0009/25/2020
Asana logo
ASAN
Asana
$29.953/29/202130,030,516$21.00$630,640,8369/30/2020
BQ
Boqii
$5.873/29/20217,000,000$10.00$70,000,0009/30/2020
Chindata Group logo
CD
Chindata Group
$17.553/29/202140,000,000$14.00$540,000,0009/30/2020
FGNAU
FG New America Acquisition
$10.703/29/202122,500,000$10.00$225,000,0009/30/2020
Orphazyme A/S logo
ORPH
Orphazyme A/S
$12.793/29/20217,616,146$11.00$83,777,6069/29/2020
QELLU
Qell Acquisition
$10.883/29/202133,000,000$10.00$330,000,0009/30/2020
VSPRU
Vesper Healthcare Acquisition
$12.313/29/202140,000,000$10.00$400,000,0009/30/2020
YALA
Yalla Group
$26.493/29/202118,600,000$8.00$139,500,0009/30/2020
Palantir Technologies logo
PLTR
Palantir Technologies
$24.223/29/2021257,135,415$7.00$1,864,231,7599/30/2020
IMPXU
AEA-Bridges Impact
$10.433/30/202140,000,000$10.00$400,000,00010/1/2020
AGCUU
Altimeter Growth
$14.373/30/202145,000,000$10.00$450,000,00010/1/2020
IGACU
IG Acquisition
$10.573/30/202130,000,000$10.00$300,000,00010/1/2020
LXEH
Lixiang Education
$8.903/30/20213,333,400$9.00$30,833,95010/1/2020
Mission Produce logo
AVO
Mission Produce
$20.393/30/20218,000,000$12.00$96,000,00010/1/2020
Pulmonx logo
LUNG
Pulmonx
$54.333/30/202110,000,000$19.00$190,000,00010/1/2020
RCHGU
Recharge Acquisition
$10.343/30/202120,000,000$10.00$200,000,00010/1/2020
THRY
Thryv
$24.083/30/202126,726,538$10.00$271,808,89110/1/2020
Academy Sports and Outdoors logo
ASO
Academy Sports and Outdoors
$25.713/31/202115,625,000$13.00$203,125,00010/2/2020
APSGU
Apollo Strategic Growth Capital
$10.453/31/202175,000,000$10.00$750,000,00010/2/2020
AVANU
Avanti Acquisition
$10.643/31/202160,000,000$10.00$600,000,00010/2/2020
C4 Therapeutics logo
CCCC
C4 Therapeutics
$40.333/31/20219,600,000$19.00$182,400,00010/2/2020
Immunome logo
IMNM
Immunome
$37.413/31/20213,250,000$12.00$39,000,00010/2/2020
Oncorus logo
ONCR
Oncorus
$15.003/31/20215,800,000$15.00$87,000,00010/2/2020
VYGGU
Vy Global Growth
$11.103/31/202150,000,000$10.00$500,000,00010/2/2020
FMACU
FirstMark Horizon Acquisition
$11.104/5/202136,000,000$10.00$360,000,00010/6/2020
MAACU
Montes Archimedes Acquisition
$10.264/5/202140,000,000$10.00$400,000,00010/7/2020
NGACU
NextGen Acquisition
$11.134/5/202135,000,000$10.00$350,000,00010/7/2020
SQFT
Presidio Property Trust
$3.874/5/2021500,000$5.00$2,500,00010/7/2020
TPGYU
TPG Pace Beneficial Finance
$21.214/5/202135,000,000$10.00$350,000,00010/7/2020
PACEU
Pace
$11.454/5/202145,000,000$10.00$450,000,00010/7/2020
Aziyo Biologics logo
AZYO
Aziyo Biologics
$14.404/6/20212,941,176$17.00$49,999,99210/8/2020
fuboTV logo
FUBO
fuboTV
$31.534/6/202118,300,000$10.00$183,000,00010/8/2020
PAICU
Petra Acquisition
$10.574/6/20217,000,000$10.00$70,000,00010/8/2020
IH
iHuman
$14.434/7/20217,000,000$12.00$84,000,00010/9/2020
Kronos Bio logo
KRON
Kronos Bio
$29.084/7/202113,157,895$19.00$250,000,00510/9/2020
LCYAU
Landcadia Holdings III
$10.864/7/202150,000,000$10.00$500,000,00010/9/2020
Shattuck Labs logo
STTK
Shattuck Labs
$33.004/7/202111,882,352$17.00$201,999,98410/9/2020
IPODU
Social Capital Hedosophia Holdings Corp. IV
$12.724/7/202140,000,000$10.00$400,000,00010/9/2020
IPOEU
Social Capital Hedosophia Holdings Corp. V
$19.964/7/202170,000,000$10.00$700,000,00010/9/2020
IPOFU
Social Capital Hedosophia Holdings Corp. VI
$12.184/7/2021100,000,000$10.00$1,000,000,00010/9/2020
Spruce Biosciences logo
SPRB
Spruce Biosciences
$17.974/7/20216,000,000$15.00$90,000,00010/9/2020
FVAM
5:01 Acquisition
$10.054/12/20218,000,000$10.00$80,000,00010/14/2020
Codiak BioSciences logo
CDAK
Codiak BioSciences
$17.924/12/20215,500,000$15.00$82,500,00010/14/2020
Array Technologies logo
ARRY
Array Technologies
$30.004/13/202147,500,000$22.00$1,045,000,00010/15/2020
Eastern Bankshares logo
EBC
Eastern Bankshares
$19.484/13/2021179,300,000$10.00$1,793,000,00010/15/2020
MINISO Group logo
MNSO
MINISO Group
$22.924/13/202130,400,000$20.00$608,000,00010/15/2020
MOTNU
Motion Acquisition
$10.294/13/202111,500,000$10.00$115,000,00010/15/2020
TMTSU
Spartacus Acquisition
$10.444/13/202120,000,000$10.00$200,000,00010/15/2020
Aligos Therapeutics logo
ALGS
Aligos Therapeutics
$22.674/14/202110,000,000$15.00$150,000,00010/16/2020
BTWNU
Bridgetown
$13.044/14/202155,000,000$10.00$550,000,00010/16/2020
Eargo logo
EAR
Eargo
$50.764/14/20217,851,852$18.00$141,333,33610/16/2020
Kiromic BioPharma logo
KRBP
Kiromic BioPharma
$10.004/14/20211,250,000$12.00$15,000,00010/16/2020
Opthea logo
OPT
Opthea
$10.184/14/20218,563,300$14.00$115,604,55010/16/2020
Praxis Precision Medicines logo
PRAX
Praxis Precision Medicines
$36.684/14/202110,000,000$19.00$190,000,00010/16/2020
Tarsus Pharmaceuticals logo
TARS
Tarsus Pharmaceuticals
$30.984/14/20215,500,000$16.00$88,000,00010/16/2020
TMPMU
Turmeric Acquisition
$10.254/14/20218,500,000$10.00$85,000,00010/16/2020
MSP
Datto
$26.854/19/202122,000,000$27.00$594,000,00010/21/2020
DCRBU
Decarbonization Plus Acquisition
$12.504/19/202120,000,000$10.00$200,000,00010/20/2020
GWACU
Good Works Acquisition
$9.994/19/202115,000,000$10.00$150,000,00010/20/2020
HIGAU
H.I.G. Acquisition
$0.004/19/202132,500,000$10.00$325,000,00010/21/2020
HLXA
Helix Acquisition
$10.304/19/202110,000,000$10.00$100,000,00010/20/2020
HZONU
Horizon Acquisition Corp II
$11.564/19/202150,000,000$10.00$500,000,00010/20/2020
LFTRU
Lefteris Acquisition
$10.594/19/202120,000,000$10.00$200,000,00010/21/2020
YGMZ
MingZhu Logistics
$5.774/19/20213,000,000$4.00$12,000,00010/21/2020
SRSAU
Sarissa Capital Acquisition
$10.784/19/202117,500,000$10.00$175,000,00010/21/2020
SPNVU
Supernova Partners Acquisition
$10.994/19/202135,000,000$10.00$350,000,00010/21/2020
Abcam logo
ABCM
Abcam
$20.754/20/20218,945,218$18.00$156,541,31510/22/2020
BLSA
BCLS Acquisition
$11.204/20/202112,500,000$10.00$125,000,00010/22/2020
CTACU
ChaSerg Technology Acquisition
$13.354/20/202125,000,000$10.00$250,000,00010/22/2020
GHLD
Guild
$15.184/20/20216,500,000$15.00$97,500,00010/22/2020
McAfee logo
MCFE
McAfee
$23.754/20/202137,000,000$20.00$740,000,00010/22/2020
RICEU
Rice Acquisition
$11.524/20/202121,500,000$10.00$215,000,00010/22/2020
TEKKU
Tekkorp Digital Acquisition
$10.594/20/202125,000,000$10.00$250,000,00010/22/2020
YSACU
Yellowstone Acquisition
$10.314/20/202112,500,000$10.00$125,000,00010/22/2020
ACACU
Acies Acquisition
$10.964/21/202120,000,000$10.00$200,000,00010/23/2020
ATACU
Atlantic Acquisition Corp. Units
$14.254/21/202125,000,000$10.00$250,000,00010/23/2020
EUCRU
Eucrates Biomedical Acquisition
$10.354/21/202110,000,000$10.00$100,000,00010/23/2020
Foghorn Therapeutics logo
FHTX
Foghorn Therapeutics
$16.874/21/20217,500,000$16.00$120,000,00010/23/2020
ACICU
Atlas Crest Investment
$11.324/26/202150,000,000$10.00$500,000,00010/28/2020
Biodesix logo
BDSX
Biodesix
$21.404/26/20214,000,000$18.00$72,000,00010/28/2020
BOACU
Bluescape Opportunities Acquisition
$10.804/26/202157,500,000$10.00$575,000,00010/28/2020
Gatos Silver logo
GATO
Gatos Silver
$13.214/26/202121,430,000$7.00$150,010,00010/28/2020
LUXAU
Lux Health Tech Acquisition
$10.874/26/202130,000,000$10.00$300,000,00010/27/2020
MACUU
Mallard Acquisition
$10.374/26/202111,000,000$10.00$110,000,00010/27/2020
MAX
MediaAlpha
$46.094/26/20219,250,000$19.00$175,750,00010/28/2020
ROOT
Root
$11.884/26/202126,830,845$27.00$724,432,81510/28/2020
ALGM
Allegro MicroSystems
$26.854/27/202125,000,000$14.00$350,000,00010/29/2020
DSACU
Duddell Street Acquisition
$10.994/27/202117,500,000$10.00$175,000,00010/29/2020
Galecto logo
GLTO
Galecto
$7.254/27/20215,666,667$15.00$85,000,00510/29/2020
Leslie's logo
LESL
Leslie's
$23.784/27/202140,000,000$17.00$680,000,00010/29/2020
AVIR
Atea Pharmaceuticals
$77.354/28/202112,500,000$24.00$300,000,00010/30/2020
BHSEU
Bull Horn
$10.554/28/20217,500,000$10.00$75,000,00010/30/2020
CONXU
CONX
$10.314/28/202175,000,000$10.00$750,000,00010/30/2020
Jupiter Wellness logo
JUPW
Jupiter Wellness
$5.554/28/2021933,333$8.00$6,999,99810/30/2020
LU
Lufax
$14.684/28/2021175,000,000$14.00$2,362,500,00010/30/2020
SQZ Biotechnologies logo
SQZ
SQZ Biotechnologies
$14.664/28/20214,411,765$16.00$70,588,24010/30/2020
DBDRU
Roman DBDR Tech Acquisition
$10.385/5/202122,000,000$10.00$220,000,00011/6/2020
ADOCU
Edoc Acquisition
$10.185/10/20219,000,000$10.00$90,000,00011/10/2020
NOACU
Natural Order Acquisition
$11.085/10/202120,000,000$10.00$200,000,00011/11/2020
TSIAU
TS Innovation Acquisitions
$13.325/10/202130,000,000$10.00$300,000,00011/10/2020
BWACU
Better World Acquisition
$11.215/12/202111,000,000$10.00$110,000,00011/13/2020
CFACU
CF Finance Acquisition Corp. III
$10.705/12/202120,000,000$10.00$200,000,00011/13/2020
DMYIU
dMY Technology Group, Inc. III
$11.715/12/202127,500,000$10.00$275,000,00011/13/2020
HAACU
Health Assurance Acquisition
$11.515/12/202150,000,000$10.00$500,000,00011/13/2020
DGNS
Dragoneer Growth Opportunities Corp. II
$10.525/17/202124,000,000$10.00$240,000,00011/17/2020
OTRAU
OTR Acquisition
$10.345/17/202110,000,000$10.00$100,000,00011/17/2020
PIPPU
Pine Island Acquisition
$10.815/17/202120,000,000$10.00$200,000,00011/17/2020
PHICU
Population Health Investment
$10.405/17/202115,000,000$10.00$150,000,00011/18/2020
ZNTEU
Zanite Acquisition
$10.805/17/202120,000,000$10.00$200,000,00011/17/2020
CHFWU
Consonance-HFW Acquisition
$10.725/18/20218,000,000$10.00$80,000,00011/19/2020
IIACU
Investindustrial Acquisition
$10.255/18/202135,000,000$10.00$350,000,00011/19/2020
JYAC
Jiya Acquisition
$9.915/18/202110,000,000$10.00$100,000,00011/19/2020
LNFAU
L&F Acquisition
$10.335/18/202115,000,000$10.00$150,000,00011/19/2020
NeoGames logo
NGMS
NeoGames
$42.795/18/20214,807,522$17.00$81,727,87411/19/2020
OLMA
Olema Pharmaceuticals
$38.145/18/202111,000,000$19.00$209,000,00011/19/2020
RTPZU
Reinvent Technology Partners Z
$10.615/18/202120,000,000$10.00$200,000,00011/19/2020
Telos logo
TLS
Telos
$33.125/18/202114,968,859$17.00$254,470,60311/19/2020
YSG
Yatsen
$13.755/18/202158,750,000$10.00$616,875,00011/19/2020
ARBGU
Aequi Acquisition
$10.255/19/202120,000,000$10.00$200,000,00011/20/2020
KWACU
Kingswood Acquisition
$10.455/19/202110,000,000$10.00$100,000,00011/20/2020
LSAQ
LifeSci Acquisition II
$10.155/19/20217,500,000$10.00$75,000,00011/20/2020
Maravai LifeSciences logo
MRVI
Maravai LifeSciences
$36.825/19/202160,000,000$27.00$1,620,000,00011/20/2020
Sotera Health logo
SHC
Sotera Health
$25.825/19/202146,600,000$23.00$1,071,800,00011/20/2020
VCVCU
10X Capital Venture Acquisition
$11.305/24/202117,500,000$10.00$175,000,00011/24/2020
HFEN
HF Enterprises
$11.225/24/20212,160,000$7.00$15,120,00011/24/2020
BREZU
Breeze Holdings Acquisition
$10.625/24/202110,000,000$10.00$100,000,00011/23/2020
GNPKU
Genesis Park Acquisition
$10.485/24/202115,000,000$10.00$150,000,00011/24/2020
Lixte Biotechnology logo
LIXT
Lixte Biotechnology
$3.785/24/20211,200,000$5.00$5,700,00011/25/2020
OZON
Ozon
$55.535/24/202133,000,000$30.00$990,000,00011/24/2020
SVSVU
Spring Valley Acquisition
$10.465/24/202120,000,000$10.00$200,000,00011/24/2020
VMAR
Vision Marine Technologies
$8.675/24/20212,400,000$10.00$24,000,00011/24/2020
RSVAU
Rodgers Silicon Valley Acquisition
$17.025/31/202120,000,000$10.00$200,000,00012/2/2020
SGAMU
Seaport Global Acquisition
$10.505/31/202112,500,000$10.00$125,000,00011/30/2020
KNTE
Kinnate Biopharma
$31.346/1/202112,000,000$20.00$240,000,00012/3/2020
LOKBU
Live Oak Acquisition Corp II
$10.836/1/202122,000,000$10.00$220,000,00012/3/2020
YQ
17 Education & Technology Group
$9.296/2/202127,400,000$10.00$287,700,00012/4/2020
FTCVU
Fintech Acquisition Corp. V
$14.006/2/202121,800,000$10.00$218,000,00012/4/2020
PTICU
PropTech Investment Co. II
$10.306/2/202120,000,000$10.00$200,000,00012/4/2020
SEER
Seer
$52.546/2/20219,210,527$19.00$175,000,01312/4/2020
SGTX
Sigilon Therapeutics
$23.536/2/20217,000,000$18.00$126,000,00012/4/2020
SBTX
Silverback Therapeutics
$51.516/2/202111,500,000$21.00$241,500,00012/4/2020
ALTUU
Altitude Acquisition
$11.256/7/202126,100,000$10.00$261,000,00012/9/2020
C3.ai logo
AI
C3.ai
$75.066/7/202115,500,000$42.00$651,000,00012/9/2020
DDMXU
DD3 Acquisition Corp. II
$10.606/7/202111,000,000$10.00$110,000,00012/8/2020
DoorDash logo
DASH
DoorDash
$135.916/7/202133,000,000$102.00$3,366,000,00012/9/2020
FLACU
Frazier Lifesciences Acquisition
$10.366/7/202112,000,000$10.00$120,000,00012/9/2020
HMCOU
Humanco Acquisition
$10.906/7/202125,000,000$10.00$250,000,00012/9/2020
MUDSU
Mudrick Capital Acquisition Co. II
$10.166/7/202127,500,000$10.00$275,000,00012/8/2020
NEBCU
Nebula Caravel Acquisition
$10.236/7/202125,000,000$10.00$250,000,00012/9/2020
PubMatic logo
PUBM
PubMatic
$50.756/7/20215,900,000$20.00$118,000,00012/9/2020
RAACU
Revolution Acceleration Acquisition
$11.356/7/202125,000,000$10.00$250,000,00012/8/2020
Airbnb logo
ABNB
Airbnb
$195.006/8/202151,323,531$68.00$3,490,000,10812/10/2020
CTAQU
Carney Technology Acquisition Corp. II
$10.096/8/202135,000,000$10.00$350,000,00012/10/2020
Hydrofarm Holdings Group logo
HYFM
Hydrofarm Holdings Group
$69.486/8/20218,666,667$20.00$173,333,34012/10/2020
PCPCU
Periphas Capital Partnering
$25.406/8/202114,400,000$25.00$360,000,00012/10/2020
RMGBU
RMG Acquisition Co. II
$10.866/8/202130,000,000$10.00$300,000,00012/10/2020
FDMT
4D Molecular Therapeutics
$43.406/9/20218,400,000$23.00$193,200,00012/11/2020
ABCL
AbCellera Biologics
$30.586/9/202124,150,000$20.00$483,000,00012/11/2020
CBAHU
CBRE Acquisition
$10.246/9/202135,000,000$10.00$350,000,00012/11/2020
Certara logo
CERT
Certara
$30.516/9/202129,055,000$23.00$668,265,00012/11/2020
DWINU
Delwinds Insurance Acquisition
$10.086/9/202117,500,000$10.00$175,000,00012/11/2020
EDTXU
EdtechX Holdings Acquisition Corp. II
$10.126/9/202110,000,000$10.00$100,000,00012/11/2020
GLAQU
Globis Acquisition
$10.466/9/202110,000,000$10.00$100,000,00012/11/2020
GHVIU
Gores Holdings VI
$16.706/9/202130,000,000$10.00$300,000,00012/11/2020
MOTVU
Motive Capital
$0.006/9/202136,000,000$10.00$360,000,00012/11/2020
Nanobiotix logo
NBTX
Nanobiotix
$16.086/9/20217,300,000$14.00$98,550,00012/11/2020
ROCCU
Roth CH Acquisition II
$10.636/9/202110,000,000$10.00$100,000,00012/11/2020
SNRHU
Senior Connect Acquisition Corp. I
$10.306/9/202136,000,000$10.00$360,000,00012/11/2020
TVACU
Thayer Ventures Acquisition
$10.296/9/202115,000,000$10.00$150,000,00012/11/2020
VVOS
Vivos Therapeutics
$7.106/9/20213,500,000$6.00$21,000,00012/11/2020
BCAB
BioAtla
$67.476/14/202110,500,000$18.00$189,000,00012/16/2020
BLUWU
Blue Water Acquisition
$10.646/14/20215,000,000$10.00$50,000,00012/15/2020
ContextLogic logo
WISH
ContextLogic
$17.986/14/202146,000,000$24.00$1,104,000,00012/16/2020
KINZU
KINS Technology Group
$10.396/14/202124,000,000$10.00$240,000,00012/15/2020
MRACU
Marquee Raine Acquisition
$10.496/14/202132,500,000$10.00$325,000,00012/15/2020
OCG
Oriental Culture
$14.196/14/20215,065,000$4.00$20,260,00012/15/2020
SCPS
Scopus BioPharma
$10.526/14/2021500,000$6.00$2,750,00012/16/2020
Upstart logo
UPST
Upstart
$164.876/14/202112,015,690$20.00$240,313,80012/16/2020
WNW
Wunong Net Technology
$12.676/14/20215,999,910$5.00$29,999,55012/15/2020
COOLU
Corner Growth Acquisition
$10.226/15/202135,000,000$10.00$350,000,00012/17/2020
Midwest logo
MDWT
Midwest
$51.306/15/20211,000,000$70.00$70,000,00012/17/2020
SCOAU
Scion Tech Growth I
$10.226/15/202150,000,000$10.00$500,000,00012/17/2020
VIRI
Virios Therapeutics
$5.426/15/20213,000,000$10.00$30,000,00012/17/2020
MASS
908 Devices
$51.286/16/20216,500,000$20.00$130,000,00012/18/2020
DUNEU
Dune Acquisition
$10.186/16/202115,000,000$10.00$150,000,00012/18/2020
IIIIU
INSU Acquisition Corp. III
$10.306/16/202121,800,000$10.00$218,000,00012/18/2020
MTACU
MedTech Acquisition
$10.326/16/202122,000,000$10.00$220,000,00012/18/2020
SVOKU
Seven Oaks Acquisition
$10.516/16/202122,500,000$10.00$225,000,00012/18/2020
VIIAU
7GC & Co. Holdings Inc.
$10.326/21/202120,000,000$10.00$200,000,00012/23/2020
ACKIU
Ackrell SPAC Partners I
$10.216/21/202112,000,000$10.00$120,000,00012/21/2020
CFIVU
CF Acquisition Corp. IV
$10.196/21/202145,000,000$10.00$450,000,00012/23/2020
GBS logo
GBS
GBS
$6.566/21/20211,270,589$17.00$21,600,01312/23/2020
HCARU
Healthcare Services Acquisition
$10.256/21/202128,800,000$10.00$288,000,00012/23/2020
Inhibikase Therapeutics logo
IKT
Inhibikase Therapeutics
$5.636/21/20211,800,000$10.00$18,000,00012/23/2020
VTAQU
Ventoux CCM Acquisition
$10.436/22/202115,000,000$10.00$150,000,00012/24/2020
MRM
MEDIROM Healthcare Technologies
$10.356/28/2021800,000$15.00$12,000,00012/29/2020
CSV / Excel Export To export this table to CSV or Excel, upgrade to MarketBeat All Access.
What is a Lock-Up Period?

Summary - When a company makes the decision to go public, they frequently register for an initial public offering (IPO) as a way to raise private equity. In the IPO prospectus, these companies will frequently include a clause that specifies a lock-up period and subsequent lock-up period expiration date. During the lock-up period, individuals that bought shares during the IPO process are prohibited from selling their shares on the secondary market for a period of time that typically ranges from 90 to 180 days. A hedge fund may institute a similar lock-up period and lock-up period expiration to allow a fund manager to generate a large return without concern of capital leaving the fund.

Although proponents of market timing pay close attention to IPO lock-up period expirations as an opportunity for both long and short sellers, there is a vocal group that argues against the need for lock-up periods at all. These proponents of the Efficient Market Hypothesis (EMH) argue that an efficient market will take into account information related to a stock and that the market is constantly accounting for that information in the share price. The theory goes on to express that any new information is immediately factored into the stock price, thus eliminating the opportunity for an individual or institutional investors to time the market. Any abnormal stock return can occur only through investing in higher risk stocks.

Introduction

For a company or hedge fund to go public, they have to raise private equity. For a hedge fund, this includes inviting investors to invest in the fund and for private companies, this typically takes place by the issuance of an initial public offering (IPO). In both cases, however, there is a significant risk of unfavorable price movement if investors were to pull their money out of the fund or stock too quickly. This is why most hedge funds and IPOs include a lock-up period. During this period, investors and shareholders are prohibited from buying and selling shares. The lock-up period expiration, therefore, is a closely watched event for investors who are following IPO stocks because the period around the lock-up expiration is usually marked by high trading volume and significant price movement. This article will go into detail about what a lock-up period is and how it is different for a hedge fund as opposed to an initial public offering. The article will also review why they are needed if they are legally required, how they differ from the quiet period expiration date, and perhaps most importantly – and controversially – do they really work?

What is a lock-up period?

A lock-up period (also known as a lock-up agreement) is a period of time (usually between 90-180 days) when investors are not allowed to buy or redeem shares. Lock-up periods can apply to hedge funds and initial public offerings. A hedge fund lock-up period will be linked to the underlying investments of the fund. If a hedge fund is comprised of mostly stocks with high liquidity, there may be a short lock-up period of 90 days. If the fund is considered to be more distressed (i.e. it is invested in low volume securities such as loans or other forms of debt), they may have a much longer lock-up period. Once the hedge fund lock-up expiration passes, investors can redeem shares according to the schedule laid out by the hedge fund. However, investors are generally required to give 30- to 90-day notice. This is to allow the hedge fund manager to liquidate underlying securities as needed. Each investor’s lock-up period expiration is tied to the date they began investing with the fund. This limits the amount of liquidation that can take place at one time.

An IPO lock-up period is a clause written into the prospectus of a company that accompanies its initial public offering (IPO). The lock-up period prohibits company insiders and other individuals who purchased stock as part of the IPO from selling their ordinary shares on the secondary market. Once the lock-up period ends (a date known as the lock-up period expiration), those shareholders can buy and sell their ordinary shares as they please.

Why is a lock-up period needed for a hedge fund?

The lock-up period is needed in order for hedge fund managers to attempt to maximize the return for investors. This can happen because, during the lock-up period, they can make an investment in securities that support the fund's goals without having to be concerned about investors redeeming shares. Without a lock-up period, the fund manager would have to ensure there was a large amount of cash or cash equivalents available which would take away from the available money to invest, thus lowering the potential return.

Why is a lock-up period needed for an IPO?

The theory behind an IPO lock-up period is that company insiders (which includes a company’s founders/owners, managers and employees) usually own a volume of shares that is disproportionate to the general public. After the initial public offering, these insiders – which can also include institutional investors, venture capitalists, and other early investors – have the most to gain from selling their shares at the higher share price created by the IPO.

If investors who bought shares of stock during the IPO were to suddenly share their shares when the stock began publicly trading, it would force the stock price down as more total shares outstanding enter the market. This increase in negative trading volume could have a long-term impact on the stock because it may curb the appetite of potential investors.

Some economists, particularly those who promote an efficient market, question if there is enough empirical evidence to support the need for a lock-up period. However, they have become a de facto clause in the prospectus for every IPO stock. The most common reasons for having a lock-up period (and a defined lock-up period expiration) include:

  1. It provides a period of time to "bridge the gap" created by information that is available to insiders prior to the IPO but is not available to the general public until after the IPO. In some cases, certain company insiders may have to wait for a period of time after the lock-up period expiration to sell their shares. This can occur during a company’s earnings season because insiders may have access to information about the company that could be construed as insider trading in the event that they were to sell their shares.
  2. It is sometimes thought of as a way for a company to create a signal regarding the quality of its stock. From Wall Street to main street, perception is reality. Most company insiders and early investors are simply looking to reward themselves with the profit that comes from taking their company public. However, to the public, this insider selling happening immediately after the initial public offering could appear to be a sign that the company is in trouble.

Are company’s legally required to set lock-up periods?

The short answer is no. In fact, a lock-up period is not required by any regulatory body including the Securities & Exchange Commission (SEC). However, they have become an almost de facto standard that is either self-imposed by the company who is launching the initial public offering or is required by the investment bank that is underwriting the IPO.

How is a lock-up period expiration different from a quiet period expiration?

Although both the lock-up period expiration date and the quiet period expiration date are used to help prevent abnormal stock returns, they happen at different times in the IPO process. The lock-up period expiration must be reached before selling activity can take place, the quiet period expiration date must be reached before buying can take place. The IPO lock-up period starts after the initial public offering is complete and goes into effect for a period of time while ordinary shares are sold on the stock exchange. The IPO quiet period takes place before the initial public offering is issued. This is a time when management and marketing teams from the company releasing the IPO are prohibited from releasing news to the public. Part of this is to prevent the real or perceived appearance of insider trading.

Do lock-up periods work?

This is a hotly debated topic within the investment community. The debate centers around the Efficient Market Hypothesis (EMH) theory. The EMH theorizes that a company’s share price reflects any and all information about the stock. Therefore, stocks will always trade at their fair value on their respective stock exchange. Proponents of the EMH would state that fundamental and technical analysis cannot be used to generate abnormal stock returns. They claim the only way to get higher returns is to purchase securities and investments that contain more risk.

According to the EMH, the lock-up period expiration is a matter of public record in the prospectus released with the IPO. With that in mind, an efficient market will take this expiration date into account before it actually happens. For example, if Company XYZ issues an IPO with a 90-day lock-up period expiration, the EMH would theorize that institutional investors and venture capitalists will automatically digest the knowledge of the IPO lock-up expiration date and initiate trading to move the share price accordingly. That way, when insider selling takes place after the lock-up expiration date occurs, the price impact will be negligible.

There is a semi-strong and a strong form of the EMH theory. The semi-strong form defines known information to be “all publicly available information”. This means that any individual can profit from that information because it is already in the public arena. The price impact of any new public information will be reflected in the company’s stock price almost immediately so a trader would have a difficult time profiting from that information. The semi-strong form would state that a lock-up period expiration date falls into the category of “publicly available information” and therefore would be incorporated into the stock price. Based on the semi-strong theory, the only way for an investor to generate higher stock returns would be to have information available to them before it became public.

The strong form defines known information to be “all pertinent information, both public and hidden”. Proponents of the strong form would claim that it was not possible for investors to generate abnormal stock returns even if they were trading on insider information.

On the other end of the argument are those investors who believe in market timing as a way to select stocks that will outperform the market. For these investors, the lock-up period expiration date becomes an ideal tool to time the market and attempt to profit during a period with either long or short selling techniques based on the anticipated price movement.

The final word on lock-up period expiration

A lock-up period expiration date can be a significant event for investors who believe in the benefits of market timing. At the end of a lock-up period, there can be significant share price movement and higher trading volume as company insiders (which includes company founders/owners and executives as well as institutional investors and venture capitalists) look to take profit after being prohibited from selling shares during the lock-up period.

A lock-up period is also frequently assigned to hedge funds. This is done so the hedge fund manager can initiate trades in accordance with the fund’s objectives without being concerned about the fund having a flight of capital from investors.

Although lock-up periods are not a legal requirement they have become a de facto standard that a company will issue voluntarily or to comply with the underwriters of the IPO. In either case, the lock-up period in an effort to protect the share price from the significant downward price movement that can occur when the early investors dump their shares. It also serves to prevent any appearance of insider trading.

The idea of using lock-up expiration dates as a form of market timing to generate abnormal stock returns is widely debated in the industry. Proponents of an efficient market use the Efficient Market Hypothesis (EMH) to claim that the market takes into account all publicly known information or any information both public and private into the stock price. Therefore, these investors would claim that the share price of an IPO stock is already pricing in the lock-up period expiration and subsequent activity surrounding it.

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257
MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement
Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.